相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Nonviable Probiotic in Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Isabelle Mack et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Continuous versus interrupted use of vaginal probiotics plus vaginal clindamycin cream for bacterial vaginosis: a randomized controlled study
Ibrahim Elsharkawy et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2021)
The Effect of Nutrition Intervention With Oral Nutritional Supplements on Ovarian Cancer Patients Undergoing Chemotherapy
Nan Qin et al.
FRONTIERS IN NUTRITION (2021)
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma
Peter Joseph DeMaria et al.
ONCOLOGIST (2021)
Is There an Exercise-Intensity Threshold Capable of Avoiding the Leaky Gut?
Filipe M. Ribeiro et al.
FRONTIERS IN NUTRITION (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma
Chaofei Xia et al.
FRONTIERS IN IMMUNOLOGY (2021)
Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities
Xiaoyan Wu et al.
MICROBIOME (2021)
The intestinal microbiota: from health to disease, and back
Nayanan N. Nathan et al.
MICROBES AND INFECTION (2021)
Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma
Nazli Dizman et al.
CANCER MEDICINE (2021)
The effectiveness of probiotics in prevention and treatment of cancer therapy-induced oral mucositis: A systematic review and meta-analysis
Zekai Shu et al.
ORAL ONCOLOGY (2020)
Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice
Yanming Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial
Chao Deng et al.
TRIALS (2020)
Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Bing Li et al.
FRONTIERS IN PHARMACOLOGY (2020)
BISQUIT: A randomized phase II study of the administration of prebiotics and probiotics during definitive treatment with chemotherapy-radiotherapy for patients with squamous cell carcinoma of the anal canal
R. Riechelmann et al.
ANNALS OF ONCOLOGY (2020)
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Sharon Elad et al.
CANCER (2020)
Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer
Blanca Prieto-Callejero et al.
MEDICINE (2020)
Effect of synbiotic supplementation on matrix metalloproteinase enzymes, quality of life and dietary intake and weight changes in rectal cancer patients undergoing neoadjuvant chemoradiotherapy
Fatemeh Farshi Radvar et al.
MEDITERRANEAN JOURNAL OF NUTRITION AND METABOLISM (2020)
Effect of Probiotics for the Prevention of Acute Radiation-Induced Diarrhoea Among Cervical Cancer Patients: a Randomized Double-Blind Placebo-Controlled Study
Ye Htut Linn et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2019)
Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis
Goda Daugelaite et al.
MEDICINA-LITHUANIA (2019)
Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study
Vitaliana De Sanctis et al.
ANTICANCER RESEARCH (2019)
A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer
Liyana Zaharuddin et al.
BMC GASTROENTEROLOGY (2019)
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic
Mary Ellen Sanders et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data
Adriana Blakaj et al.
ORAL ONCOLOGY (2019)
Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study
Ezgi Bellikci-Koyu et al.
NUTRIENTS (2019)
A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma
Chunling Jiang et al.
CANCER (2019)
Effects of probiotics on chemotherapy in patients with lung cancer
Yang Tian et al.
ONCOLOGY LETTERS (2019)
Shared mechanisms among probiotic taxa: implications for general probiotic claims
Mary Ellen Sanders et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
Sa1838 - The Clinical and Circulating Inflammatory Cytokines Effects of Probiotic Containing Lactobacillus and Bifidobacterium Strains in Patients with Colorectal Cancer: A Randomized Double Blind Controlled Trial
Raja Affendi Raja Ali et al.
GASTROENTEROLOGY (2018)
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203
Ann H. Klopp et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre/probiotics in chronic kidney disease: a systematic review
Rita de Cassia Stampini Oliveira Lopes et al.
NUTRICION HOSPITALARIA (2018)
Probiotic Species in the Modulation of Gut Microbiota: An Overview
Md. Abul Kalam Azad et al.
BIOMED RESEARCH INTERNATIONAL (2018)
VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice
Chun-Sai-Er Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children
David Schnadower et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effect of symbiotic supplementation on fecal calprotectin levels and lactic acid bacteria, Bifidobacteria, Escherichia coli and Salmonella DNA in patients with cervical cancer
Luis Humberto de Loera-Rodriguez et al.
NUTRICION HOSPITALARIA (2018)
Probiotics for the prevention or treatment of chemotherapyor-radiotherapy-related diarrhoea in people with cancer
Dang Wei et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Strain-specific probiotic (microbial cell preparation) and omega-3 fatty acid in modulating quality of life and inflammatory markers in colorectal cancer patients: a randomized controlled trial
Babak Golkhalkhali et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
Probiotic Survey in Cancer Patients Treated in the Outpatient Department in a Comprehensive Cancer Center
Sona Ciernikova et al.
INTEGRATIVE CANCER THERAPIES (2017)
Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection treated cytokine-induced killer cells combined with chemotherapy in the treatment of malignancies
Chaoqi Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
The resilience of the intestinal microbiota influences health and disease
Felix Sommer et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Influence of Orally Administered Probiotic Lactobacillus Strains on Vaginal Microbiota in Women with Breast Cancer during Chemotherapy: A Randomized Placebo-Controlled Double-Blinded Pilot Study
Julian Marschalek et al.
BREAST CARE (2017)
Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients
Masaaki Motoori et al.
CLINICAL NUTRITION (2017)
A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer
M. E. Lacouture et al.
ANNALS OF ONCOLOGY (2016)
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments
Rachel M. McQuade et al.
FRONTIERS IN PHARMACOLOGY (2016)
Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study
Michal Mego et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2015)
Probiotics for Prevention and Treatment of Diarrhea
Alfredo Guarino et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
The history of probiotics: the untold story
M. Ozen et al.
BENEFICIAL MICROBES (2015)
Efficacy of Bifidobacterium Tetragenous Viable Bacteria Tablets for Cancer Patients with Functional Constipation
Jin Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (GynoflorA®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study
Gilbert Donders et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma
Marijo Bilusic et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation
Jamie E. Chaft et al.
CLINICAL LUNG CANCER (2014)
A randomized double-blind controlled trial: Impact of probiotics on diarrhea in patients treated with pelvic radiation
Mimi Demers et al.
CLINICAL NUTRITION (2014)
Guidance on the management of diarrhoea during cancer chemotherapy
Jervoise Andreyev et al.
LANCET ONCOLOGY (2014)
Catabolism of Glucose and Lactose in Bifidobacterium animalis subsp lactis, Studied by 13C Nuclear Magnetic Resonance
Irene Gonzalez-Rodriguez et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2013)
Phase 1b, Multicenter, Single Blinded, Placebo-Controlled, Sequential Dose Escalation Study to Assess the Safety and Tolerability of Topically Applied AG013 in Subjects With Locally Advanced Head and Neck Cancer Receiving Induction Chemotherapy
Sewanti Atul Limaye et al.
CANCER (2013)
Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7)
Dmytro A. Butov et al.
IMMUNOTHERAPY (2013)
Colonic Methane Production Modifies Gastrointestinal Toxicity Associated With Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer
Reetta Holma et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanoma
Ferdinando C. M. Cananzi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
J. Stebbing et al.
ANNALS OF ONCOLOGY (2012)
Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study
Atul Sharma et al.
EUROPEAN JOURNAL OF CANCER (2012)
Probiotics, their health benefits and applications for developing healthier foods: a review
Ravinder Nagpal et al.
FEMS MICROBIOLOGY LETTERS (2012)
Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial
F. N. Sari et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2011)
Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways
Peter van Baarlen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies
Mariko Wada et al.
SUPPORTIVE CARE IN CANCER (2010)
A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages
Wei Xia et al.
BLOOD (2009)
Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine
John Stanford et al.
IMMUNOTHERAPY (2009)
Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung
J. L. Stanford et al.
EUROPEAN JOURNAL OF CANCER (2008)
An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer
P. M. Patel et al.
EUROPEAN JOURNAL OF CANCER (2008)
Prevention of recurrence with epirubicin and Lactobacillus casei after transurethral resection of bladder cancer
Seiji Naito et al.
JOURNAL OF UROLOGY (2008)
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer:: a randomised study
P. Osterlund et al.
BRITISH JOURNAL OF CANCER (2007)
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74.: Phase II study
M Mego et al.
SUPPORTIVE CARE IN CANCER (2006)
Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies
Rachel J. Gibson et al.
SUPPORTIVE CARE IN CANCER (2006)
Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa
S Di Caro et al.
DIGESTIVE AND LIVER DISEASE (2005)
Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer
RJ Gibson et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
A randomized pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy
L Assersohn et al.
CLINICAL ONCOLOGY (2002)
A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma
MER O'Brien et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
